| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
|
Giampieri, Riccardo
|
|
|
|
1 |
p. 161-169
|
artikel
|
| 2 |
Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia
|
Thomas, Xavier
|
|
2019
|
|
1 |
p. 33-65
|
artikel
|
| 3 |
Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think?
|
Yılmaz, Umut
|
|
|
|
1 |
p. 157-161
|
artikel
|
| 4 |
ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
|
Ortega-Franco, Ana
|
|
|
|
1 |
p. 13-22
|
artikel
|
| 5 |
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
|
Arriola, Edurne
|
|
|
|
1 |
p. 167-184
|
artikel
|
| 6 |
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?
|
Agostinetto, Elisa
|
|
|
|
1 |
p. 19-29
|
artikel
|
| 7 |
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma
|
Barrett, Louise
|
|
|
|
1 |
p. 129-143
|
artikel
|
| 8 |
Anesthesia Medications and Interaction with Chemotherapeutic Agents
|
Watson, Jeremy
|
|
|
|
1 |
p. 121-138
|
artikel
|
| 9 |
A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach
|
Wang, Xiaomin
|
|
|
|
1 |
p. 91-102
|
artikel
|
| 10 |
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario
|
Di Lorenzo, Giuseppe
|
|
|
|
1 |
p. 147-155
|
artikel
|
| 11 |
A Review of Fulvestrant in Breast Cancer
|
Nathan, Mark R.
|
|
2017
|
|
1 |
p. 17-29
|
artikel
|
| 12 |
A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected
|
Winer, Eric S.
|
|
2018
|
|
1 |
p. 9-20
|
artikel
|
| 13 |
Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are
|
Rommasi, Foad
|
|
|
|
1 |
p. 23-54
|
artikel
|
| 14 |
Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature
|
Quintela, Adrien
|
|
2017
|
|
1 |
p. 111-118
|
artikel
|
| 15 |
Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis
|
Allison, Eleanor
|
|
|
|
1 |
p. 27-48
|
artikel
|
| 16 |
Carcinoma In Situ Involving Sclerosing Adenosis on Core Biopsy: Diagnostic Pearls to Aid the Practicing Clinician and Avoid Overtreatment
|
Richards, Dana
|
|
|
|
1 |
p. 81-89
|
artikel
|
| 17 |
Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions
|
Yan, Zhi-Ling
|
|
|
|
1 |
p. 85-103
|
artikel
|
| 18 |
Characteristics of Laryngeal Osteosarcoma: A Critical Review
|
Mäkitie, Antti A.
|
|
|
|
1 |
p. 33-44
|
artikel
|
| 19 |
Chordoma: The Quest for Better Treatment Options
|
Heery, Christopher R.
|
|
2016
|
|
1 |
p. 35-51
|
artikel
|
| 20 |
Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study
|
Ejerskov, Cecilie
|
|
|
|
1 |
p. 97-110
|
artikel
|
| 21 |
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis
|
Lough, Tony
|
|
2018
|
|
1 |
p. 73-85
|
artikel
|
| 22 |
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma
|
Parra, Luis
|
|
2016
|
|
1 |
p. 129-134
|
artikel
|
| 23 |
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
|
Ang, Celina
|
|
2016
|
|
1 |
p. 1-16
|
artikel
|
| 24 |
Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective
|
Habr, Dany
|
|
|
|
1 |
p. 25
|
artikel
|
| 25 |
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
|
Metro, Giulio
|
|
|
|
1 |
p. 173-174
|
artikel
|
| 26 |
Correction to: Uveal Melanoma: A Review of the Literature
|
Singh, Manni
|
|
2019
|
|
1 |
p. 93
|
artikel
|
| 27 |
Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina
|
Wurcel, Victoria
|
|
|
|
1 |
p. 167-185
|
artikel
|
| 28 |
64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
|
Mirzaei, Siroos
|
|
|
|
1 |
p. 125-131
|
artikel
|
| 29 |
Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review
|
Parks, Ruth M.
|
|
|
|
1 |
p. 55-67
|
artikel
|
| 30 |
Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
|
Claveau, Jean-Sébastien
|
|
|
|
1 |
p. 105-122
|
artikel
|
| 31 |
Current Status and Study Progress of Recombinant Human Endostatin in Cancer Treatment
|
Li, Kai
|
|
2017
|
|
1 |
p. 21-43
|
artikel
|
| 32 |
Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia
|
Cook, Gordon
|
|
|
|
1 |
p. 139-151
|
artikel
|
| 33 |
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
|
Habr, Dany
|
|
|
|
1 |
p. 115-129
|
artikel
|
| 34 |
DNA Mutations May Not Be the Cause of Cancer
|
Adjiri, Adouda
|
|
2017
|
|
1 |
p. 85-101
|
artikel
|
| 35 |
Donor-Derived Leukemia in a Recipient of Double-Unit Cord Blood Transplantation for Acute Myeloid Leukemia: A Case Study and Literature Review
|
Plesa, Adriana
|
|
|
|
1 |
p. 75-84
|
artikel
|
| 36 |
Effectiveness, Tolerability, and Safety of Ectoine-Containing Mouthwash Versus Those of a Calcium Phosphate Mouthwash for the Treatment of Chemotherapy-Induced Oral Mucositis: A Prospective, Active-Controlled, Non-interventional Study
|
Dao, Van Anh
|
|
2018
|
|
1 |
p. 59-72
|
artikel
|
| 37 |
Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A Systematic Review and Meta-Analysis
|
Pei, Yaping
|
|
|
|
1 |
p. 55-73
|
artikel
|
| 38 |
Efficacy and Safety Results of the Afatinib Expanded Access Program
|
Kim, Edward S.
|
|
2017
|
|
1 |
p. 103-110
|
artikel
|
| 39 |
Emerging Concepts Impacting Head and Neck Cancer Surgery Morbidity
|
Ronen, Ohad
|
|
|
|
1 |
p. 1-13
|
artikel
|
| 40 |
Erratum to: Chordoma: The Quest for Better Treatment Options
|
Heery, Christopher R.
|
|
2016
|
|
1 |
p. 53-55
|
artikel
|
| 41 |
Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada
|
Vanderpuye-Orgle, Jackie
|
|
|
|
1 |
p. 195-210
|
artikel
|
| 42 |
Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK
|
Frank, Pauline
|
|
|
|
1 |
p. 97-114
|
artikel
|
| 43 |
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)
|
Hata, Akito
|
|
|
|
1 |
p. 253-262
|
artikel
|
| 44 |
Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer
|
Bloem, Lourens T.
|
|
2016
|
|
1 |
p. 103-116
|
artikel
|
| 45 |
From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa
|
Dlamini, Zodwa
|
|
|
|
1 |
p. 1-11
|
artikel
|
| 46 |
Gender Differences and Outcomes in Melanoma Patients
|
Morgese, Francesca
|
|
|
|
1 |
p. 103-114
|
artikel
|
| 47 |
Genetic Pathway in the Pathogenesis of Therapy-Related Myeloid Neoplasms: A Literature Review
|
Tiruneh, Tegenaw
|
|
|
|
1 |
p. 45-57
|
artikel
|
| 48 |
Global Longitudinal Strain: Is It Time to Change the Preoperative Cardiac Assessment of Oncology Patients?
|
Shehata, Islam Mohammad
|
|
|
|
1 |
p. 13-19
|
artikel
|
| 49 |
Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
|
Borchmann, Peter
|
|
|
|
1 |
p. 65-81
|
artikel
|
| 50 |
Health-Related Quality of Life as a Prognostic Measure of Clinical Outcomes in Renal Cell Carcinoma: A Review of the CheckMate 025 Trial
|
Grimm, Marc-Oliver
|
|
2017
|
|
1 |
p. 75-78
|
artikel
|
| 51 |
Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature Review
|
Korol, Ellen E.
|
|
2017
|
|
1 |
p. 1-16
|
artikel
|
| 52 |
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
|
Berardi, Rossana
|
|
|
|
1 |
p. 115-124
|
artikel
|
| 53 |
Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma
|
Serra-Roma, André
|
|
|
|
1 |
p. 133-145
|
artikel
|
| 54 |
Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer
|
Adjiri, Adouda
|
|
2016
|
|
1 |
p. 17-33
|
artikel
|
| 55 |
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke
|
Belluomini, Lorenzo
|
|
2019
|
|
1 |
p. 83-91
|
artikel
|
| 56 |
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
|
Alpuim Costa, Diogo
|
|
|
|
1 |
p. 225-240
|
artikel
|
| 57 |
Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report
|
Greene, Claire
|
|
|
|
1 |
p. 247-253
|
artikel
|
| 58 |
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature
|
Baglivo, Sara
|
|
|
|
1 |
p. 291-300
|
artikel
|
| 59 |
Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis
|
Howard, J. Harrison
|
|
2016
|
|
1 |
p. 57-72
|
artikel
|
| 60 |
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies
|
diZerega, Gere S.
|
|
|
|
1 |
p. 31-55
|
artikel
|
| 61 |
Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy
|
Luveta, Jocelyn
|
|
|
|
1 |
p. 1-11
|
artikel
|
| 62 |
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
|
De Lisa, Mariagrazia
|
|
|
|
1 |
p. 147-160
|
artikel
|
| 63 |
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
|
Ko, Heidi
|
|
|
|
1 |
p. 13-17
|
artikel
|
| 64 |
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
|
Barbier, Sandrine
|
|
|
|
1 |
p. 111-128
|
artikel
|
| 65 |
Liquid Chromatography–Mass Spectrometry/Mass Spectrometry Analysis and Pharmacokinetic Assessment of Ponatinib in Sprague–Dawley Rats
|
Wang, Pei
|
|
2016
|
|
1 |
p. 117-128
|
artikel
|
| 66 |
Living with Advanced Kidney Cancer and Treatment with Cabozantinib: Through the Eyes of the Patient and the Physician
|
Storbjerg, Bent
|
|
2018
|
|
1 |
p. 1-7
|
artikel
|
| 67 |
Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature
|
Hermida, Gerardo
|
|
|
|
1 |
p. 183-188
|
artikel
|
| 68 |
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab
|
Bernabé, Reyes
|
|
|
|
1 |
p. 175-182
|
artikel
|
| 69 |
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature
|
Kruse, Megan L.
|
|
|
|
1 |
p. 279-289
|
artikel
|
| 70 |
Measuring the Patient Experience in Rare Disorders: Benefit of Pragmatic Mixed-Methods Research in NUT Carcinoma
|
Ciesluk, Anna
|
|
|
|
1 |
p. 263-277
|
artikel
|
| 71 |
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
|
Søreide, Kjetil
|
|
|
|
1 |
p. 1-12
|
artikel
|
| 72 |
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
|
Pepe, Francesco
|
|
|
|
1 |
p. 73-95
|
artikel
|
| 73 |
Oesophageal Adenocarcinoma: A Patient and Physician’s Perspective
|
Maule, Derek
|
|
2017
|
|
1 |
p. 79-84
|
artikel
|
| 74 |
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program
|
Santos, Edgardo S.
|
|
2018
|
|
1 |
p. 45-58
|
artikel
|
| 75 |
Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects
|
Singh, Avineesh
|
|
2016
|
|
1 |
p. 73-89
|
artikel
|
| 76 |
Parenteral Nutrition in Advanced Cancer: The Healthcare Providers’ Perspective
|
Balstad, Trude R.
|
|
|
|
1 |
p. 211-223
|
artikel
|
| 77 |
Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
|
Filicevas, Alex
|
|
|
|
1 |
p. 1-11
|
artikel
|
| 78 |
Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
|
Cheng, Rebecca
|
|
|
|
1 |
p. 123-141
|
artikel
|
| 79 |
Patient Reported Outcomes (PROs) as Part of Value-Based Care Can Shape Therapy Guidelines: Impact on Emerging Targeted Agents and Immunotherapy Protocols in Resource-Limited Regions
|
Mott, Frank E.
|
|
2017
|
|
1 |
p. 69-74
|
artikel
|
| 80 |
Patients at the Heart of the Scientific Dialogue: An Industry Perspective
|
Habr, Dany
|
|
|
|
1 |
p. 15-24
|
artikel
|
| 81 |
Patient Survey of the Physical, Emotional, and Informational Challenges for Patients Living with Neuroendocrine Tumors
|
Khan, Mohid S.
|
|
|
|
1 |
p. 67-80
|
artikel
|
| 82 |
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors
|
Chen, Hong
|
|
|
|
1 |
p. 131-145
|
artikel
|
| 83 |
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
|
Karam, Dhauna
|
|
|
|
1 |
p. 69-88
|
artikel
|
| 84 |
Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature Review
|
Cobo, Manuel
|
|
|
|
1 |
p. 41-53
|
artikel
|
| 85 |
Qualitatively Comparing the Support Needs of People with Cancer Based on Their History of Anxiety/Depression
|
Richardson, Emma M.
|
|
2017
|
|
1 |
p. 41-51
|
artikel
|
| 86 |
Real-World Impact of Physician and Patient Discordance on Health-Related Quality of Life in US Patients with Acute Myeloid Leukemia
|
Horvath Walsh, L. Elise
|
|
2019
|
|
1 |
p. 67-81
|
artikel
|
| 87 |
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
|
Alegre, Adrián
|
|
|
|
1 |
p. 83-96
|
artikel
|
| 88 |
Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States
|
Rice, Megan S.
|
|
|
|
1 |
p. 195-212
|
artikel
|
| 89 |
Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature
|
Stecca, Carlos E.
|
|
|
|
1 |
p. 21-39
|
artikel
|
| 90 |
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
|
Metro, Giulio
|
|
|
|
1 |
p. 163-171
|
artikel
|
| 91 |
Review of the Agnostic-Type Treatment Approach: Treating Cancer by Mutations, Not by Location
|
Rosas, Daniel
|
|
|
|
1 |
p. 59-66
|
artikel
|
| 92 |
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
|
Chhaya, Saachi
|
|
|
|
1 |
p. 49-64
|
artikel
|
| 93 |
Second-line Treatments for Advanced Gastric Cancer: A Network Meta-Analysis of Overall Survival Using Parametric Modelling Methods
|
Harvey, Rebecca C.
|
|
2017
|
|
1 |
p. 53-67
|
artikel
|
| 94 |
Seminoma Retroperitoneal Relapse 23 Years After Surgery
|
Crocetti, Sonia
|
|
|
|
1 |
p. 239-245
|
artikel
|
| 95 |
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus
|
Desai, Chirag
|
|
|
|
1 |
p. 143-165
|
artikel
|
| 96 |
Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps
|
Kleive, Dyre
|
|
|
|
1 |
p. 111-120
|
artikel
|
| 97 |
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
|
Thomas, Xavier
|
|
|
|
1 |
p. 57-72
|
artikel
|
| 98 |
Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men
|
Katongole, Paul
|
|
|
|
1 |
p. 185-193
|
artikel
|
| 99 |
Stapler-Assisted Pharyngeal Closure After Total Laryngectomy: A Systematic Review and Meta-Analysis
|
Chiesa-Estomba, Carlos M.
|
|
|
|
1 |
p. 241-252
|
artikel
|
| 100 |
Switching from an LHRH Antagonist to an LHRH Agonist: A Case Report of 10 Finnish Patients with Advanced Prostate Cancer
|
Visapää, Harri
|
|
2017
|
|
1 |
p. 119-123
|
artikel
|
| 101 |
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
|
Schey, Steve
|
|
2016
|
|
1 |
p. 31-40
|
artikel
|
| 102 |
The Perspectives of Haematological Cancer Patients on Tissue Banking
|
Turon, Heidi
|
|
2016
|
|
1 |
p. 91-102
|
artikel
|
| 103 |
The Role of UK Oncogene-Focussed Patient Groups in Supporting and Educating Patients with Oncogene-Driven NSCLC: Results from a Patient-Devised Survey
|
Abbott, Jenny
|
|
|
|
1 |
p. 187-193
|
artikel
|
| 104 |
The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics
|
Chan, Hiu Ting
|
|
2018
|
|
1 |
p. 1-32
|
artikel
|
| 105 |
The Time Has Come for Targeted Therapies for AML: Lights and Shadows
|
Fiorentini, Alessandro
|
|
|
|
1 |
p. 13-32
|
artikel
|
| 106 |
The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab
|
Goldschmidt, Jerome
|
|
|
|
1 |
p. 213-223
|
artikel
|
| 107 |
The Treatment of Non-Melanoma Skin Cancer with Image-Guided Superficial Radiation Therapy: An Analysis of 2917 Invasive and In Situ Keratinocytic Carcinoma Lesions
|
Yu, Lio
|
|
|
|
1 |
p. 153-166
|
artikel
|
| 108 |
Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations
|
Kolberg, Hans-Christian
|
|
|
|
1 |
p. 225-238
|
artikel
|
| 109 |
Uveal Melanoma: A Review of the Literature
|
Singh, Manni
|
|
2018
|
|
1 |
p. 87-104
|
artikel
|
| 110 |
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review
|
Rodríguez, July
|
|
|
|
1 |
p. 89-110
|
artikel
|
Tijdschrift beschrijving